A new indolocarbazole derivative in melanoma and carcinoma lung in vivo treatment
Abstract Objective The current scientific research direction is development of drugs with a targeted effect on malignant tumors. One of the promising groups is indolocarbazoles and their derivatives, which can initiate various tumor cell death pathways. Russian scientists from N. N. Blokhin National...
Saved in:
Main Authors: | Anna Lantsova (Author), Irina Golubeva (Author), Larisa Borisova (Author), Lyudmila Nikolaeva (Author), Lydia Ektova (Author), Maria Dmitrieva (Author), Olga Orlova (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and validation of HPLC method for analysis of indolocarbazole derivative LCS-1269
by: Zoya Shprakh, et al.
Published: (2021) -
ANTITUMOR DRUGS BASED ON INDOLOCARBAZOL DERIVATIVES
by: I. P. Kolpaksidi, et al.
Published: (2021) -
Antiproliferative activity of a new derivative from the class of N-glycoside of indolo[2,3-a]pyrrolo[3,4-c]carbazoles
by: Marina P. Kiseleva, et al.
Published: (2022) -
The Development of a Parenteral Pharmaceutical Formulation of a New Class of Compounds of Nitrosourea
by: Ludmila Nikolaeva, et al.
Published: (2016) -
MODERN ONCO DRUG FOR INTERNAL USE
by: O. L. Orlova, et al.
Published: (2018)